AppYea, Inc. (APYP)
| Market Cap | 6.84M |
| Revenue (ttm) | 29.00K |
| Net Income (ttm) | -4.03M |
| Shares Out | 534.76M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 125,220 |
| Average Volume | 15,736 |
| Open | 0.0168 |
| Previous Close | 0.0100 |
| Day's Range | 0.0100 - 0.0128 |
| 52-Week Range | 0.0100 - 0.0325 |
| Beta | -0.20 |
| RSI | 48.28 |
| Earnings Date | Mar 31, 2025 |
About AppYea
AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. It develops AppySleep app, a wristband that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns in the sleep and identify sleep arena episode without direct contact to the user; and AppySleep PRO a wristband for the treatment of sleep arena using biofeedback in combination with AppySleep LAB app. The comp... [Read more]
Financial Performance
Financial StatementsNews
AppYea Launches Smart Biofeedback-Based Wristband to Address Snoring
Wristband connects to an app on iPhone or Android to detect snoring and activates gentle vibrations, prompting users to change their sleeping position NEW YORK , Sept. 30, 2024 /PRNewswire/ -- AppYea ...
AppYea Chairman Bary Molchadsky Demonstrates Confidence by Converting Debt to Warrants with a Strike Price Set at a 250% Premium to Current Market Price of the Company's Common Stock
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / AppYea Inc. (OTCQB:APYP), developer of an innovative wearable monitoring solution to monitor and treat sleep apnea and snoring, today announced the conversio...
AppYea Launches E-Commerce Store on Amazon Broadening Distribution
AppySleep smart wristband now available on Amazon Successful fulfillment of all pre-orders Entering the 17.9 Billion Sleep Tech Device Market GAN YAVNE, ISRAEL / ACCESSWIRE / March 20, 2024 / AppYea, I...
AppYea Enters Commercial Phase with First Deliveries of AppySleep to Customers in the U.S.
AppySleep now available for purchase online Plans to sell the product in stores as part of planned second phase of rollout GAN YAVNE, ISRAEL / ACCESSWIRE / January 10, 2024 / AppYea, Inc. (OTCQB:APYP)...
AppYea Provides Year-End Letter to Shareholders Recapping Key Achievements and Sharing Outlook for 2024
GAN YAVNE, ISRAEL / ACCESSWIRE / December 13, 2023 / AppYea Inc. (OTCQB:APYP), focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, today provided th...
AppYea Secures US Patent for Innovative Sleep Apnea Detection Using Speech Analysis
New Patent Promises Affordable and Convenient Sleep Apnea Diagnostics; Market Projected to Reach US$ 9.27 Billion by 2033 GAN YAVNE, ISRAEL / ACCESSWIRE / August 28, 2023 / SleepX, a subsidiary of App...
AppYea Announces Equity Financing Transaction to Accelerate Commercial Launch
Transaction expected to streamline capital structure and ultimately result in the elimination of all Company debt GAN YAVNE, ISRAEL / ACCESSWIRE / August 3, 2023 / AppYea Inc. (OTC:APYP), a healthtech...
AppYea Announces Appointment of Leading Medical Device Industry Executive Adi Shemer as CEO
GAN YAVNE, ISRAEL / ACCESSWIRE / July 31, 2023 / AppYea Inc. (OTC:APYP), which is focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, today announced...
Leading Operations Executive Adi Shemer Joins AppYea's Advisory Board
GAN YAVNE, ISRAEL / February 16, 2023 / AppYea Inc. (OTCQB:APYP), a developer of accurate wearable monitoring solutions to treat sleep apnea and snoring, is pleased to announce the addition of Adi She...
Ron Mekler Joins AppYea's Board of Directors Audit Committee Chair
GAN YAVNE, ISRAEL / ACCESSWIRE / January 23, 2023 / AppYea Inc. (OTCQB:APYP) which focuses on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, is pleased to ...